The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tanashyan M.M.

Neurology Research Center, Moscow, Russia

Lagoda O.V.

Research Centre of Neurology, Moscow, Russia

Antonova K.V.

Neurology Research Center, Moscow, Russia

Konovalov R.N.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Chronic cerebrovascular diseases and metabolic syndrome: approaches to pathogenic therapy of cognitive dysfunction

Authors:

Tanashyan M.M., Lagoda O.V., Antonova K.V., Konovalov R.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(9): 106‑110

DOI: 10.17116/jnevro201611691106-110

Read: 3128 times

Download PDF (RU)
Contact the author
Table of contents

CHRONIC CEREBROVASCULAR DISEASES AND METABOLIC SYNDROME: APPROACHES TO PATHOGENIC THERAPY OF COGNITIVE DYSFUNCTION
CHRONIC CEREBROVASCULAR DISEASES AND METABOLIC SYNDROME: APPROACHES TO PATHOGENIC THERAPY OF COGNITIVE DYSFUNCTION

To cite this article:

Tanashyan MM, Lagoda OV, Antonova KV, Konovalov RN. Chronic cerebrovascular diseases and metabolic syndrome: approaches to pathogenic therapy of cognitive dysfunction. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(9):106‑110. (In Russ.)
https://doi.org/10.17116/jnevro201611691106-110

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Comparative study of cognitive impairment in subgroups of bipo­lar affe­ctive diso­rder types I and II, occu­rring with and without psychotic symptoms. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):7-11
Cognitive functions asse­ssment of elde­rly patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):46-50
Rela­tionship between stroke-associated pneumonia and long-term outcomes of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):57-61
5q spinal muscular atro­phy in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):142-147
Increased expression of circular RNA circSPARC and circTMEM181 in coro­nary athe­rosclerosis. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(1):24-29
The influence of demo­graphic factors and major como­rbidities on serum circulating regu­latory microRNAs in patients with coro­nary artery athe­rosclerosis and thoracic aortic aneurysm: a single-center cohort study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):174-182
The place of non-high-density lipo­protein cholesterol and triglycerides in the asse­ssment of cardiovascular risk: Reso­lution of the Panel of Expe­rts. Russian Journal of Preventive Medi­cine. 2025;(4):7-15
Study of the levo­carnitine effi­cacy for the treatment of mode­rate cognitive impairment in patients with hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(4):45-50
Neutrophil elastase as a promising biomarker of low-grade inflammation in chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2025;(4):142-148
Treatment and prevention of suture failure and bleeding after various bariatric inte­rventions. Piro­gov Russian Journal of Surgery. 2025;(5):79-85
Abstract:

Cognitive decline comprises one of the most important symptoms of chronic cerebral hypoperfusion. It leads not only to social disability of the patients with a subsequent decline in life quality but also to a decrease in adequate control of the course of both vascular pathology and comorbid states. Pathogenetic therapy and prevention of cerebrovascular disease progression, along with general medical measures, should include the drugs normalizing different symptoms of metabolic syndrome (arterial hypertension, diabetes mellitus etc) as well as complex drugs with multiple actions (hemangioma correction, antithrombotic, antioxidant and vasoactive) actions.

Keywords:

cerebrovascular disease
metabolic syndrome
atherosclerosis
cognitive disorders
pathogenic therapy

Authors:

Tanashyan M.M.

Neurology Research Center, Moscow, Russia

Lagoda O.V.

Research Centre of Neurology, Moscow, Russia

Antonova K.V.

Neurology Research Center, Moscow, Russia

Konovalov R.N.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Close metadata

References:

  1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics-2012 Update: A Report From the American Heart Association. Circulation. 2012;125:188-197.  doi: 10.1161/CIR.0b013e3182456d46
  2. Stahovskaja LV, Klochihina OA, Bogatyreva MD, Kovalenko VV. Jepidemiologija insul'ta v Rossii po rezul'tatam territorial'no-populjacionnogo registra (2009—2010). Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2013;113(5):4-10. (In Russ.).
  3. Estol C. Atherosclerosis: The XXIst Century Epidemic: A Meeting at the Vatican. Stroke. 2011;42(12):3338-3339. doi: 10.1161/strokeaha.111.640300
  4. Bakker F, Klijn C, Jennekens-Schinkel A, Kappelle L. Cognitive disorders in patients with occlusive disease of the carotid artery: a systematic review of the literature. Journal of Neurology. 2000;247(9):669-676.  doi: 10.1007/s004150070108
  5. Suslina ZA, Tanashjan MM, Lagoda OV. Ateroskleroz i ishemicheskie narushenija mozgovogo krovoobrashhenija. Aterotromboz. 2009;2(3):60-67. (In Russ.).
  6. Deedwania PC. Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease? Circulation. 2004;109:2-41.  doi: 10.1161/01.CIR.0000110642.73995.BF
  7. Antonini-Canterin F, La Carrubba S, Gullace G et al. Associacion Between Carotid Atherosclerosis and Metabolic Syndrome: Results From the ISMIR Study. Angiology. 2010;61(5):443-448.  doi: 10.1177/0003319709360523
  8. Maksimovic M, Vlajinac H, Radak D, Maksimovic J, Otasevic P et al. Frequency and characteristics of metabolic syndrome in patients with symptomatic carotid atherosclerosis. Rev Med Chile. 2009;137:329-336.  doi: S0034-98872009000300002
  9. Preobrazhenskaja IS, Jahno NN. Vozrastnaja kognitivnaja disfunkcija: diagnostika i lechenie. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2006;11(106):33-38. (In Russ.).
  10. Cerebrovascular disease, cognitive impairment and dementia. Second edition of Cerebrovascular disease and dementia. Ed. by O'Brien J, Ames D., Gustafson L., Folstein M., Chie E. Martin Dunitz. 2004.
  11. Zaharov VV. Jevoljucija kognitivnogo deficita: legkie i umerennye kognitivnye narushenija. Nevrologija, nejropsihiatrija, psihosomatika. 2012;2:16-21. (In Russ.).
  12. Shprah VV, Sajutina SB, Romazina TA. Lechenie kognitivnyh narushenij pri serdechno-sosudistyh zabolevanijah. Metodicheskie rekomendacii. Irkutsk: RIO IGIUVa; 2009. (In Russ.).
  13. Jahno NN, Zaharov VV, Sosina VB. Nedementnye kognitivnye narushenija u bol'nyh saharnym diabetom 2-go tipa. Nevrologicheskij zhurnal. 2010;4:25-30. (In Russ.).
  14. Cosentino F, Battista, MD R, Scuteri A et al. Impact of Fasting Glycemia and Regional Cerebral Perfusion in Diabetic Subjects. Stroke. 2009;40:306-308.  doi: 10.1161/STROKEAHA.108.520627
  15. Raffaitin C, Féart C, Le Goff M, Amieva H, Helmer C, Akbaraly TN, Tzourio C, Gin H, Barberger-Gateau P. Metabolic syndrome and cognitive decline in French elders: the Three-City Study. Neurology. 2011;76(6):518-525.  doi: 10.1212/WNL.0b013e31820b765:1526-632X
  16. Tanashjan MM, Lagoda OV, Orlov SV, Telenkova NG, Maksjutkina LN, Petruhina SJu. Sosudistye zabolevanija golovnogo mozga i metabolicheskij sindrom. i 2013;10(85):34-42. (In Russ.).
  17. Lebedeva NV, Zareckaja IH, Kozlova EN i dr. Primenenie preparata kavinton v medicinskoj praktike. M. 1979. (In Russ.).
  18. Kozlova EN, Usman VB, Lobkova TN. Primenenie kavintona dlja lechenija sosudistyh zabolevanij golovnogo mozga s uchetom vozrastnyh osobennostej. M. 1983. (In Russ.).
  19. Lebedeva NV. Znachenie preparata kavinton v lechenii bol'nyh s ostroj i hronicheskoj sosudistoj mozgovoj nedostatochnost'ju. Kavinton i vozmozhnosti ego primenenija v medicinskoj praktike. M. 1986. (In Russ.).
  20. Suslina ZA, Tanashjan MM, Maksimova MJu, Kistenev BA, Ionova VG, Sharypova TN. Kavinton (vinpocetin) v lechenii bol'nyh s ostrymi i hronicheskimi formami sosudistyh zabolevanij golovnogo mozga: novye aspekty terapii. Farmateka. 2004;14:99-104. (In Russ.).
  21. Nagy Z, Vargha P, Kovacs L et al. Metaanalysis of cavinton. Praxis. 1998;7:63-68.
  22. Hindmarch I, Fuchs H, Erzigkeit H. Efficacy and Tolerance of Vinpocetine in Ambulant Patients Suffering from Mild to Moderate Organic Psychosyndromes. Int Clin Psychopharmacology. 1991;6(1):31-44.  doi: 10.1097/00004850-199100610-00005
  23. Zhivolupov SA, Samarcev IN, Jakovlev EV, Butakova JuS, Bodrova TV. Ocenka jeffektivnosti vinpocetina (kavintona komforte) v lechenii golovokruzhenija u pacientov s discirkuljatornoj jencefalopatiej po urovnju nejrotroficheskogo faktora mozga (BDNF) v plazme krovi. Klinicheskaja farmakologija i terapija. 2016;25(1):49-54. (In Russ.).
  24. Suslina ZA, Tanashjan MM, Ionova VG, Kistenev BA, Maksimova MJu, Sharypova TN. Kavinton v lechenii bol'nyh s ishemicheskimi narushenijami mozgovogo krovoobrashhenija — novye aspekty dejstvija. Lechenie nervnyh boleznej. 2002;3(3):19-24. (In Russ.).
  25. Tanashjan MM, Lagoda OV, Fedin PA, Konovalov RN, Rodionova JuV, Suslina ZA. Primenenie vinpocetina dlja lechenija kognitivnyh narushenij u bol'nyh s hronicheskimi cerebrovaskuljarnymi zabolevanijami. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2007;107:10:41-43. (In Russ.).
  26. Tanashjan MM, Lagoda OV, Fedin PA, Konovalov RN, Rodionova JuV. Sovremennye podhody k lecheniju bol'nyh s hronicheskimi sosudistymi zabolevanijami golovnogo mozga. Atmosfera. Nervnye bolezni. 2010;4:19-22. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.